Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
| 17 | 3 | IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL | 124793 |
| 201 | 2 | IMMUNOTHERAPY//DENDRITIC CELLS//MYELOID DERIVED SUPPRESSOR CELLS | 20719 |
| 26296 | 1 | ENDOSIALIN//CD248//TEM1 | 280 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | ENDOSIALIN | authKW | 3424177 | 12% | 89% | 34 |
| 2 | CD248 | authKW | 1600845 | 6% | 89% | 16 |
| 3 | TEM1 | authKW | 703491 | 4% | 63% | 10 |
| 4 | ENDOTHELIAL LIKE DIFFERENTIATION | authKW | 562798 | 2% | 100% | 5 |
| 5 | TEM7 | authKW | 562798 | 2% | 100% | 5 |
| 6 | TUMOR ENDOTHELIAL MARKER | authKW | 405210 | 2% | 60% | 6 |
| 7 | ANTIANGIOGENIC CANCER VACCINE | authKW | 337679 | 1% | 100% | 3 |
| 8 | MORAB 004 | authKW | 337679 | 1% | 100% | 3 |
| 9 | ONTUXIZUMAB | authKW | 337679 | 1% | 100% | 3 |
| 10 | CELL PROTEOMIC FOOTPRINTING | authKW | 225119 | 1% | 100% | 2 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 1911 | 43% | 0% | 121 |
| 2 | Medicine, Research & Experimental | 483 | 16% | 0% | 46 |
| 3 | Immunology | 385 | 19% | 0% | 53 |
| 4 | Cell Biology | 132 | 13% | 0% | 36 |
| 5 | Cell & Tissue Engineering | 30 | 1% | 0% | 3 |
| 6 | Genetics & Heredity | 25 | 5% | 0% | 15 |
| 7 | Biotechnology & Applied Microbiology | 19 | 5% | 0% | 14 |
| 8 | Pathology | 17 | 3% | 0% | 8 |
| 9 | Hematology | 12 | 3% | 0% | 8 |
| 10 | Biochemistry & Molecular Biology | 11 | 10% | 0% | 28 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | BCS FR | 112560 | 0% | 100% | 1 |
| 2 | BCSFRDFRDVPTTOXTOXR | 112560 | 0% | 100% | 1 |
| 3 | CANC BIOTHER Y ONCOL | 112560 | 0% | 100% | 1 |
| 4 | CANC KASHIWA | 112560 | 0% | 100% | 1 |
| 5 | CANCER IMMUNOTHER Y | 112560 | 0% | 100% | 1 |
| 6 | CLIN ONCOL UNIT CLIN ONCOL | 112560 | 0% | 100% | 1 |
| 7 | CNRS ECOLE SUPER BIOTECHNOL STRASBOURG | 112560 | 0% | 100% | 1 |
| 8 | DIPARTIMENTO SCI PSICOL SALUTE TERRRITO | 112560 | 0% | 100% | 1 |
| 9 | GEN SURGSECT 3 | 112560 | 0% | 100% | 1 |
| 10 | GENOM GRP PROTE | 112560 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 2042 | 3% | 0% | 9 |
| 2 | JOURNAL OF TRANSLATIONAL MEDICINE | 1138 | 2% | 0% | 5 |
| 3 | JOURNAL OF IMMUNOTHERAPY | 1048 | 1% | 0% | 4 |
| 4 | GENE EXPRESSION PATTERNS | 1003 | 1% | 0% | 3 |
| 5 | ONCOTARGET | 821 | 4% | 0% | 11 |
| 6 | INTERNATIONAL JOURNAL OF ONCOLOGY | 726 | 3% | 0% | 8 |
| 7 | MICROVASCULAR RESEARCH | 662 | 1% | 0% | 4 |
| 8 | BMC IMMUNOLOGY | 630 | 1% | 0% | 2 |
| 9 | EMBO MOLECULAR MEDICINE | 625 | 1% | 0% | 2 |
| 10 | VACCINE | 593 | 4% | 0% | 10 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ENDOSIALIN | 3424177 | 12% | 89% | 34 | Search ENDOSIALIN | Search ENDOSIALIN |
| 2 | CD248 | 1600845 | 6% | 89% | 16 | Search CD248 | Search CD248 |
| 3 | TEM1 | 703491 | 4% | 63% | 10 | Search TEM1 | Search TEM1 |
| 4 | ENDOTHELIAL LIKE DIFFERENTIATION | 562798 | 2% | 100% | 5 | Search ENDOTHELIAL+LIKE+DIFFERENTIATION | Search ENDOTHELIAL+LIKE+DIFFERENTIATION |
| 5 | TEM7 | 562798 | 2% | 100% | 5 | Search TEM7 | Search TEM7 |
| 6 | TUMOR ENDOTHELIAL MARKER | 405210 | 2% | 60% | 6 | Search TUMOR+ENDOTHELIAL+MARKER | Search TUMOR+ENDOTHELIAL+MARKER |
| 7 | ANTIANGIOGENIC CANCER VACCINE | 337679 | 1% | 100% | 3 | Search ANTIANGIOGENIC+CANCER+VACCINE | Search ANTIANGIOGENIC+CANCER+VACCINE |
| 8 | MORAB 004 | 337679 | 1% | 100% | 3 | Search MORAB+004 | Search MORAB+004 |
| 9 | ONTUXIZUMAB | 337679 | 1% | 100% | 3 | Search ONTUXIZUMAB | Search ONTUXIZUMAB |
| 10 | CELL PROTEOMIC FOOTPRINTING | 225119 | 1% | 100% | 2 | Search CELL+PROTEOMIC+FOOTPRINTING | Search CELL+PROTEOMIC+FOOTPRINTING |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |